Trial NCT02382406

View at ClinicalTrials.gov 
Org. Study IDs: HCRN LUN13-175

Last trial update was posted on 2023-05-23

MeSH Interventions

Carboplatin Paclitaxel Pembrolizumab

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-Small Cell Lung Cancer

Stopping Reasons

The study was completed. It was fully accrued.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID